High-throughput screening identifies a critical role of the SPOP–PABPC1 axis in lung adenocarcinoma progression
Proceedings of the National Academy of Sciences · 2026
DOI: 10.1073/pnas.2602470123 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2026. Verfasst von Jiahui Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang 330006, China. Hauptthemen laut MEDLINE: Repressor Proteins, Nuclear Proteins, Lung Neoplasms, Adenocarcinoma of Lung. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MOST | National Natural Science Foundation of China (NSFC).
Abstract (Originalsprache)
Lung adenocarcinoma (LUAD) is the most common and deadly subtype of lung cancer, with limited therapeutic options and poor prognosis. Ubiquitination is an important posttranslational modification (PTM) that controls protein turnover, localization and interaction. The dysregulated ubiquitination machinery is a hallmark of cancer, contributing to tumor development. Identifying key E3 ubiquitin ligases and deubiquitinases in LUAD could lead to new biomarkers and treatments. Through RNA sequencing, bioinformatics, and clinical studies, SPOP has been identified as a promising E3 ligase target in LUAD. SPOP is downregulated in LUAD samples and associated with poorer patient outcomes. Functional analyses demonstrate that SPOP suppresses LUAD cell migration, proliferation, and in vivo tumor growth. Mechanistically, SPOP targets poly(A)-binding protein cytoplasmic 1 (PABPC1) for nonproteolytic ubiquitination, leading to its nuclear retention and inhibition of global protein synthesis, thereby suppressing the oncogenic effects of PABPC1. Furthermore, the deubiquitinase HAUSP is able to counteract SPOP-mediated ubiquitination of PABPC1, enhancing its oncogenic role in LUAD cells. Collectively, our findings reveal a SPOP/HAUSP-PABPC1 regulatory axis in LUAD, where SPOP and HAUSP oppositely modulate PABPC1 ubiquitination to control LUAD cell proliferation and migration. This axis represents a promising therapeutic target in LUAD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang 330006, China.
- Department of Thoracic Surgery, the First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang 330006, China.
- Key Laboratory of Biodiversity Conservation and Bioresource Utilization of Jiangxi Province, College of Life Sciences, Jiangxi Normal University, Nanchang 330006, China.
- Queen Mary College, Nanchang University, Nanchang 330006, China.
- College of Life Sciences, Shandong Agricultural University, Tai'an 271018, China.
ORCID-Profile: Jiahui Zhang, Zizhang Zhou
Förderung
- MOST | National Natural Science Foundation of China (NSFC)
Zitieren
APA
Zhang, J., Liu, R., Han, X., Jiao, Y., Peng, Y., Zhou, Z., Deng, Y., & Gong, L. (2026). High-throughput screening identifies a critical role of the SPOP–PABPC1 axis in lung adenocarcinoma progression. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2602470123
Vancouver
Zhang J, Liu R, Han X, Jiao Y, Peng Y, Zhou Z, et al. High-throughput screening identifies a critical role of the SPOP–PABPC1 axis in lung adenocarcinoma progression. Proceedings of the National Academy of Sciences. 2026. doi:10.1073/pnas.2602470123
BibTeX
@article{Zhang2026,
author = {Zhang, Jiahui and Liu, Ran and Han, Xue and Jiao, Yutong and Peng, Yun and Zhou, Zizhang and Deng, Yanran and Gong, Lianggeng},
title = {High-throughput screening identifies a critical role of the SPOP–PABPC1 axis in lung adenocarcinoma progression},
journal = {Proceedings of the National Academy of Sciences},
year = {2026},
doi = {10.1073/pnas.2602470123}
}
EUVIMED